VIRUS TODAY: 2nd vaccine draws closer to FDA approval
A second COVID-19 vaccine has won backing from a panel of experts
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Here's what's happening Thursday with the coronavirus pandemic in the U.S.:
THREE THINGS TO KNOW TODAY
— A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic as a panel of experts endorsed its safety and effectiveness, paving way for a final decision by the Food and Drug Administration on emergency use.
— An overwhelming amount of false information clung to COVID-19 as it circled the globe in 2020, from speculation that the coronavirus was created in a lab to hoax cures.
— The number of Americans applying for unemployment benefits rose again last week to 885,000, the highest weekly total since September, as a resurgence of coronavirus cases threatens the economy’s recovery from its springtime collapse.
THE NUMBERS: The seven-day rolling average for daily new deaths in the U.S. increased over the past two weeks from 1,606 on Dec. 2 to 2,570 on Wednesday, according to data from Johns Hopkins University.
DEATH TOLL: The U.S. death toll stands at 309,334 people, or about the population of St. Paul, Minnesota.
QUOTABLE: “This is coming much faster than what anybody thought. Something that might have otherwise taken several years — to take this new vaccine technology and test it and approve it — was compressed into within a year.” — Dr. Jesse Goodman of Georgetown University, former chief of the FDA s vaccine division.
ICYMI: The Associated Press' pandemic atlas offers a look at the coronavirus in the U.S. by the numbers.
ON THE HORIZON: The FDA’s green light for emergency use of the Moderna vaccine is expected quickly. Moderna would then begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
___
Find AP’s full coverage of the coronavirus pandemic at https://apnews.com/hub/coronavirus-pandemic